US FDA analysis blames poor quality 510(k) submissions for delays in reviews
This article was originally published in RAJ Devices
Executive Summary
The time it takes for the US Food and Drug Administration to review 510(k) applications for clearing medical devices has increased because of industry's failure to file submissions of an adequate quality, an internal analysis by the FDA has revealed1.